"O-alkylhydroxylamines as rationally-designed mechanism-based inhibitors of indoleamine 2,3-dioxygenase-1." Malachowski WP, Winters M, DuHadaway JB, Lewis-Ballester A, Badir S, Wai J, Rahman M, Sheikh E, LaLonde JM, Yeh SR, Prendergast GC, Muller AJ.
Eur J Med Chem. 108, 564-76, 2016.
“Spectroscopic and mutagenesis studies of human PGRMC1.” Kaluka D, Batabyal D, Chiang BY, Poulos TL, Yeh SR. Biochemistry. 54, 1638-47, 2015.
“Catalytic intermediates of inducible nitric oxide synthase stabilized by the W188H mutation.” Sabat J, Egawa T, Lu C, Stuehr DJ, Gerfen GJ, Rousseau DL, Yeh SR. J Biol Chem. 288, 6095-106, 2013.
“Ferryl derivatives of human indoleamine 2,3-dioxygenase” Lu C, Yeh SR. J Biol Chem. 286, 21220-30, 2011.
“Molecular basis for the substrate stereoselectivity in tryptophan dioxygenase.” Capece L, Lewis-Ballester A, Marti MA, Estrin DA, Yeh SR., Biochemistry, 50, 10910-8, 2011.
“Spectroscopic Studies of Ligand and Substrate Binding to Human Indoleamine 2,3-Dioxygenase.” Lu C, Lin Y, Yeh SR. Biochemistry, 49, 5028-34, 2010.
"Evidence for a ferryl intermediate in a heme-based dioxygenase." Lewis-Ballester A, Batabyal D, Egawa T, Lu C, Lin Y, Marti MA, Capece L, Estrin DA, Yeh SR. Proc Natl Acad Sci U S A. 106, 17371-6, 2009.
"Inhibitory substrate binding site of human indoleamine 2,3-dioxygenase." Lu C, Lin Y, Yeh SR. J Am Chem Soc.131, 12866-7, 2009.
"Substrate-protein interaction in human tryptophan dioxygenase: the critical role of H76." Batabyal D, Yeh SR. J Am Chem Soc. 131, 3260-70, 2009.
"Design and evaluation of a passive alcove-based microfluidic mixer." Egawa T, Durand JL, Hayden EY, Rousseau DL, Yeh SR. Anal Chem. 81, 1622-7, 2009.